-
The true function of the meniscofemoral ligaments remains unclear, but it may have profound implications for treatment of PCL-deficient knees and lateral meniscal tears.
-
In one of the more bizarre stories of the year, the FDA has uncovered files of counterfeit Procrit (epoetin alfaJohnson & Johnson) in routine surveillance.
-
Senior management at CryoCath Technologies (Montreal, Quebec) was elated over the result of an FDA advisory panel meeting last month, despite a list of conditions the company must now address.
-
Women who undergo open-heart surgery are more likely than men to develop acute renal failure (ARF), according to research conducted at The Cleveland Clinic (Cleveland, Ohio).
-
AST Products (Billerica, Massachusetts), a developer of water-based coatings for medical devices, has completed a licensing agreement with MicroPort Medical (Shanghai, China) for its LubriLAST coating.
-
Abiomed (Danvers, Massachusetts) last month rolled out plans to develop a new line of ventricular-assist devices, suggesting both a return to its initial development effort and an inflection point in its progress with the AbioCor replacement heart program.
-
Here is the Centers for Disease Control and Preventions guidance for the management of exposure to severe acute respiratory syndrome in health care settings.
-
This article outlines symptoms of suspected and probable cases of severe acute respiratory syndrome according to the Centers for Disease Control and Prevention.
-
Physicians commonly use a wide array of medications to treat bronchiolitis, a common lower-respiratory tract disease among infants and toddlers, but there is no compelling evidence to support these treatments, according to a new evidence report sponsored by the Agency for Healthcare Research and Quality.
-
Anxiety often is poorly managed in patients recovering from a heart attack, new research reports.1